Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2030

Conditions
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative ColitisIndeterminate ColitisFunctional Abdominal Pain SyndromeFunctional Bowel DisorderEsophageal DiseasesGastroduodenal DisorderBowel DysfunctionGallbladder DiseasesSphincter of Oddi DysfunctionAnorectal Disorder
Interventions
DIAGNOSTIC_TEST

Esophagogastroduodenoscopy (EGD) with biopsy

Esophagogastroduodenoscopy (EGD) is a test procedure to examine the lining of the esophagus, stomach, and first part of the small intestine.

DIAGNOSTIC_TEST

Colonoscopy w/ biopsy

Colonoscopy is a test procedure to examine the lining of the different portions of the large intestine: cecum, colon, rectum, and anal canal.

Trial Locations (1)

98105

RECRUITING

Seattle Children's Hospital, Seattle

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Allen Institute

UNKNOWN

lead

Seattle Children's Hospital

OTHER

NCT06315179 - Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) | Biotech Hunter | Biotech Hunter